{"log_id": 5446386890456140370, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0.006391, "average": 0.979899, "min": 0.485124}, "location": {"width": 871, "top": 118, "height": 67, "left": 139}, "words": "慰剂对照试验中,本品组和安慰剂组患者的死率分别为4.0%和3.1%。死亡患者的平均年龄"}, {"probability": {"variance": 0.00101, "average": 0.990095, "min": 0.867351}, "location": {"width": 286, "top": 187, "height": 43, "left": 141}, "words": "为86岁范围在67100岁之间)"}, {"probability": {"variance": 0.000786, "average": 0.981736, "min": 0.916636}, "location": {"width": 161, "top": 233, "height": 36, "left": 188}, "words": "12与呋塞米合用"}, {"probability": {"variance": 0.000966, "average": 0.991413, "min": 0.815626}, "location": {"width": 829, "top": 247, "height": 65, "left": 187}, "words": "在对老年痴呆患者用本品进行的安慰剂对照研究中,利培酮与呋塞米合并用药患者的死"}, {"probability": {"variance": 0.002964, "average": 0.97789, "min": 0.729408}, "location": {"width": 845, "top": 291, "height": 68, "left": 144}, "words": "亡率高于单独使用利培酮或呋塞米的患者,分别为7.3%(平均年龄89岁,范铜75-97岁)"}, {"probability": {"variance": 0.020181, "average": 0.949166, "min": 0.364845}, "location": {"width": 873, "top": 334, "height": 69, "left": 145}, "words": "31%(平均年龄84岁,范70-9岁)和4.1%平均年龄80岁,范围67-90岁)。在4项临"}, {"probability": {"variance": 0.001664, "average": 0.982793, "min": 0.777561}, "location": {"width": 635, "top": 387, "height": 60, "left": 148}, "words": "床试验中的2项观察到了合用呋塞米和本品的患者死亡率增加的现象"}, {"probability": {"variance": 0.000386, "average": 0.99105, "min": 0.896962}, "location": {"width": 806, "top": 423, "height": 63, "left": 193}, "words": "尽管尚未找到明确的病理生理学机制来解释这一现象,并且患者的死亡原因也不相同"}, {"probability": {"variance": 0.001772, "average": 0.977228, "min": 0.856951}, "location": {"width": 870, "top": 465, "height": 66, "left": 152}, "words": "但对老年患者合并给与利培酮和呋塞米时需谨慎评估风险利益。在服用利培酮并合用其它利尿"}, {"probability": {"variance": 0.003582, "average": 0.975365, "min": 0.750729}, "location": {"width": 846, "top": 508, "height": 66, "left": 156}, "words": "剂的患者中,并未出现以上死亡率增加的现象:由于脱水是老年痴呆患者很重要的致死因素"}, {"probability": {"variance": 0, "average": 0.999523, "min": 0.998762}, "location": {"width": 259, "top": 575, "height": 41, "left": 155}, "words": "所以应尽量避免脱水的发生"}, {"probability": {"variance": 0.000285, "average": 0.990941, "min": 0.937199}, "location": {"width": 207, "top": 625, "height": 28, "left": 156}, "words": "2.脑血管意外(CAE)"}, {"probability": {"variance": 0.008622, "average": 0.97446, "min": 0.41245}, "location": {"width": 827, "top": 633, "height": 64, "left": 201}, "words": "在对老年痴呆患者(平均年龄85岁,范7397岁)进行的安慰剂对照研究中,观察到"}, {"probability": {"variance": 0.00485, "average": 0.983082, "min": 0.550651}, "location": {"width": 872, "top": 675, "height": 66, "left": 158}, "words": "利培酮组包括死亡在内的脑血管方面不良事件(脑血管意外和短暂性脑缺血发作的发生率较安"}, {"probability": {"variance": 0.000105, "average": 0.991217, "min": 0.974324}, "location": {"width": 89, "top": 754, "height": 28, "left": 160}, "words": "慰剂组高"}, {"probability": {"variance": 0.02147, "average": 0.942624, "min": 0.483587}, "location": {"width": 230, "top": 789, "height": 35, "left": 160}, "words": "3.对α受体的阻断活性"}, {"probability": {"variance": 0.003743, "average": 0.97781, "min": 0.72266}, "location": {"width": 828, "top": 803, "height": 62, "left": 206}, "words": "由于本品具有对α受体的阻断作用,可能会发生(体位性)低血压,尤其是在治疗初期的"}, {"probability": {"variance": 0.001967, "average": 0.984719, "min": 0.731185}, "location": {"width": 868, "top": 844, "height": 66, "left": 165}, "words": "剂量调整阶段。上市后合用抗高血压药物时,曾观察到有临床意义的低血压。对于已知患有心"}, {"probability": {"variance": 0.005175, "average": 0.972995, "min": 0.600649}, "location": {"width": 869, "top": 886, "height": 66, "left": 166}, "words": "血管疾病的患者(如心衰、心肌梗塞、传导异常、脱水、血睿量降低或脑血管疾病)应慎用本"}, {"probability": {"variance": 0.00043, "average": 0.991609, "min": 0.905239}, "location": {"width": 441, "top": 946, "height": 50, "left": 167}, "words": "品,剂量应按推荐剂量逐渐增加(见用法用量)"}, {"probability": {"variance": 0.004612, "average": 0.969553, "min": 0.751902}, "location": {"width": 346, "top": 922, "height": 64, "left": 650}, "words": "血低现象,应考虑减少剂量"}, {"probability": {"variance": 0.034254, "average": 0.915628, "min": 0.363261}, "location": {"width": 363, "top": 992, "height": 44, "left": 210}, "words": "迟发性运动障碍/锥体外系症状 TD/EPS"}, {"probability": {"variance": 0.018466, "average": 0.947226, "min": 0.378505}, "location": {"width": 806, "top": 1010, "height": 74, "left": 214}, "words": "同其它所有具有多巴胺受体抗剂性质的药物相一本能引起迟发性运动障碍"}, {"probability": {"variance": 0.010979, "average": 0.961376, "min": 0.527449}, "location": {"width": 874, "top": 1055, "height": 70, "left": 172}, "words": "其特征为有节律的非自主运动,主要见于舌及面部有报告表,雄体外系症状的发生是迟发"}, {"probability": {"variance": 0.023701, "average": 0.938282, "min": 0.46562}, "location": {"width": 851, "top": 1097, "height": 70, "left": 174}, "words": "性运动障碍发展的风险因素,而与其它传统抗精布病药比,誉品较少引起锥体外系症状"}, {"probability": {"variance": 0.001239, "average": 0.989733, "min": 0.783264}, "location": {"width": 871, "top": 1140, "height": 66, "left": 175}, "words": "因此与传统抗精神病药物相比,本品引发迟发性运动障碍的风险较低。如果出现迟发性运"}, {"probability": {"variance": 0.000622, "average": 0.993609, "min": 0.88499}, "location": {"width": 511, "top": 1196, "height": 54, "left": 175}, "words": "动障碍的症状,应考虑停用所有的抗精神病药"}, {"probability": {"variance": 0.008084, "average": 0.963371, "min": 0.637658}, "location": {"width": 334, "top": 1249, "height": 42, "left": 177}, "words": "5.抗精神病药的恶性综合征NMS"}, {"probability": {"variance": 0.004908, "average": 0.982993, "min": 0.569139}, "location": {"width": 829, "top": 1267, "height": 66, "left": 222}, "words": "已有报告指出,服用传统的抗精神病药可能会出现恶性综合征,其特征为高热、肌肉僵"}, {"probability": {"variance": 0.011045, "average": 0.949744, "min": 0.53542}, "location": {"width": 871, "top": 1311, "height": 64, "left": 180}, "words": "直、颤抖、意识障碍和血清肌酸磷酸激水平升高,还可能出现肌红蛋白尿症(横纹肌溶解"}, {"probability": {"variance": 0.000124, "average": 0.995521, "min": 0.954308}, "location": {"width": 603, "top": 1363, "height": 55, "left": 182}, "words": "症)和急性肾衰。此时应停用包括本品在内的所有抗精神病药物"}, {"probability": {"variance": 0.067082, "average": 0.735934, "min": 0.476933}, "location": {"width": 64, "top": 1527, "height": 22, "left": 987}, "words": " Page II"}, {"probability": {"variance": 0.009393, "average": 0.833187, "min": 0.76088}, "location": {"width": 200, "top": 1555, "height": 30, "left": 166}, "words": " I CCDS aug-02-jan 05"}, {"probability": {"variance": 0.003776, "average": 0.933393, "min": 0.871941}, "location": {"width": 41, "top": 1585, "height": 19, "left": 193}, "words": " of 16"}], "language": 3}